Literature DB >> 6788060

Identification of a common oncofoetal protein in x-ray and chemically induced rat gastrointestinal tumours.

R H Stevens, D A Cole, H F Cheng.   

Abstract

An apparently unique circulating common oncofoetal protein has been identified in rat small-bowel, colonic and pancreatic adenocarcinomas. The tumours were induced by ionizing radiation (small bowel), an alkyl hydrocarbon, 1,2-dimethylhydrazine (colon) and a polyaromatic hydrocarbon, 7,12-dimethylbenz[a]anthracene (pancreas). The oncofoetal protein was identified by the use of specific xenogenic antitumour rabbit sera generated to the X-ray-induced neoplasm. In addition, the foetal protein was also found always to occur in the liver and lungs of those animals bearing the chemically induced tumours as well as in their serum. These results suggest the existence of a close relationship at the molecular level in the tumorigenic processes, even though induction is by apparently different mechanisms, for cancers arising in tissue or common embryonic origin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788060      PMCID: PMC2010725          DOI: 10.1038/bjc.1981.120

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats.

Authors:  B S Reddy; T Narisawa; P Wright; D Vukusich; J H Weisburger; E L Wynder
Journal:  Cancer Res       Date:  1975-02       Impact factor: 12.701

2.  An animal model for the study of small-bowel tumors.

Authors:  K L Coop; J G Sharp; J W Osborne; G R Zimmerman
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

3.  Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats.

Authors:  J M Ward
Journal:  Lab Invest       Date:  1974-04       Impact factor: 5.662

4.  Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas.

Authors:  G Steele; H O Sjögren
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

5.  Retrogenetic expression: the reappearance of embryonal antigens in cancer cells.

Authors:  E H Stonehill; A Bendich
Journal:  Nature       Date:  1970-10-24       Impact factor: 49.962

6.  Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells?

Authors:  P Alexander
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

7.  Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors.

Authors:  G Steele; H O Sjögren; J E Rosengren; C Lindström; A Larsson; L Leandoer
Journal:  J Natl Cancer Inst       Date:  1975-04       Impact factor: 13.506

8.  Experimental induction of pancreatic adenocarcinoma in rats.

Authors:  J Dissin; L R Mills; D L Mains; O Black; P D Webster
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

9.  Oncofetal protein accompanying irradiation-induced small-bowel adenocarcinoma in the rat.

Authors:  R H Stevens; C W England; J W Osborne; H F Cheng; H B Richerson
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

10.  Elevated concentrations of serum alpha-fetoprotein in rats with chemically induced liver tumors.

Authors:  R Kroes; J M Sontag; S Sell; G M Williams; J H Weisburger
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

View more
  2 in total

1.  Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.

Authors:  M Gubersky; D M Thomson; M Lajzerowicz
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Cell-mediated cytotoxicity expressed by lymphoid cells from rats with asbestos-induced peritoneal mesothelioma towards rat fetal cell.

Authors:  R H Stevens; D A Cole; H F Cheng; J A Hodge; L A Will
Journal:  Environ Health Perspect       Date:  1983-09       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.